AtriCure (ATRC) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $59.05 +1.25%
EPS Growth %: -300.0%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -300.0%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.32), $0.03 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $84.5 million versus the consensus estimate of $79.67 million.
GUIDANCE:
AtriCure sees FY2022 EPS of ($1.07)-($1.12), versus the consensus of ($1.10). AtriCure sees FY2022 revenue of $323-333 million, versus the consensus of $324.43 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Amrize Ltd (AMRZ) PT Lowered to $42 at UBS on Lower Earnings Estimates
- Thor Industries (THO) Misses Q4 EPS by 13c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
